HOTH News and Press, Hoth Therapeutics Inc. From 01/04/22

InvestorPlace - Stock Market News, Stock Advice & Trading Tips One of the hottest stocks in the market today is Hoth Therapeutics (NASDAQ: HOTH ). Indeed, HOTH stock has more than doubled on incredible volume today as investors price in a very significant catalyst. Source: luc...

Hoth Therapeutics Announces HT-ALZ Therapeutic Shows Positive Results - Reduce Amyloid β in Alzheimer's Disease Significant decrease in Aβ seen in an Alzheimer's disease mouse model after acute treatment with HT-ALZ, supporting that HT-ALZ has the potential to modi...

Hoth Therapeutics Announces Submission of Orphan Drug Designation Request for HT-KIT to Treat Mastocytosis PR Newswire NEW YORK , Dec. 21, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH) a patient-focused clinical-stage biopharmaceutica...

Hoth Therapeutics Licenses Lupus Therapeutic Back to Zylö Therapeutics Hoth to receive shares in Zylö and potential future sales royalties PR Newswire NEW YORK , Dec. 8, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage b...

Hoth Therapeutics' Enrollment and Dosing in Second Cohort in Phase 1b Human Trial for Atopic Dermatitis Under Way PR Newswire NEW YORK , Nov. 30, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company focused ...

Hoth Therapeutics (NASDAQ:HOTH) has signed a sponsored research agreement with North Carolina State University for the development of HT-KIT, an mRNA therapeutic for mast cell cancers. The research will center on characterizing the HT-KIT dose and  frequency for treatment of aggressive m...

Hoth Therapeutics Announces a Sponsored Research Agreement to Further Develop Novel mRNA Cancer Therapeutic HT-KIT PR Newswire NEW YORK , Nov. 16, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, ...

Hoth Therapeutics Inks API and Drug Product Contracts with WuXi STA to Advance Manufacturing of HT-KIT Cancer Therapeutic WuXi STA, is a leading manufacturer of GMP morpholino oligonucleotides (PMOs) PR Newswire NEW YORK , Nov. 8, 2021 /PRNewswire/ -- H...

Hoth Therapeutics Extends Partnership Agreement with REPROCELL PR Newswire NEW YORK , Oct. 19, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc . (NASDAQ: HOTH) has extended its partnership agreement with REPROCELL to assess the effect of the HT-003 th...

Hoth Therapeutics Receives Approval to Commence Cohort 2 in Clinical Trial of BioLexa for the Treatment of Atopic Dermatitis Patients PR Newswire NEW YORK , Oct. 12, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical compan...